Michael Schilawski, OD
Optometrist · Wilmington, NCNPI 1972811321
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,388 of the $10,902 with a category attached, or 86.1%. 19 manufacturers reported payments, led by Alcon at 43.0% of the total. Among optometrist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 262 payments — averaging $41.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$5K
- Coopervision Inc.$2K
- Bausch & Lomb Americas Inc.$2K
- Johnson & Johnson Vision Care, Inc.$694
- Bausch & Lomb, A Division Of Bausch Health US, LLC$572
- Oyster Point Pharma, Inc.$292
- plus $954 from 13 others
What the payments were for
- Consulting fees$4254%
- Travel & lodging$1,0169%
- Food & beverage$9,38886%
- Education$360%
- Entertainment$380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 76 | $4,693 |
| Coopervision Inc. | 47 | $1,894 |
| Bausch & Lomb Americas Inc. | 64 | $1,803 |
| Johnson & Johnson Vision Care, Inc. | 10 | $694 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 22 | $572 |
| Oyster Point Pharma, Inc. | 13 | $292 |
| Biotissue Holdings Inc. | 2 | $232 |
| Sun Pharmaceutical Industries Inc. | 7 | $127 |
| AbbVie | 3 | $126 |
| NEW World Medical,inc. | 1 | $124 |
| Tarsus Pharmaceuticals, Inc. | 4 | $93 |
| Novartis | 3 | $63 |
| Kala Pharmaceuticals, Inc. | 4 | $60 |
| Optos, Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Dompe US, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $16 |
| Aerie Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOTAL30$1,126
- DAILIES$654
- AIR OPTIX$634
- Precision 1$614
- Precision7$520
- INFUSE$470
- Acuvue$425
- DAILIES TOTAL1$384
- Clariti Contact Lens$365
- MyDay Contact Lens$325
- TRYPTYR$124
- BIOTRUE$124
- VYZULTA$123
- PanOptix$120
- Rocklatan$104
- Rhopressa$104
- SIMBRINZA$104
- Multiple Brands Contact Lens$104
How this compares
$10,902 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 25 | $30,362 |
| Lotemax SmLoteprednol Etabonate | 14 | $3,441 |
| Prednisolone Acetate | 57 | $1,558 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 32 | $1,491 |
| Latanoprost | 73 | $1,005 |
| Timolol Maleate | 22 | $499 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $276 |
| Brimonidine Tartrate | 11 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $126 | $30,36225 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLotemax Sm | $572 | $3,44114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,326 optometrist providers in North Carolina.
Other optometrist in Wilmington
- Crystal BrimerWilmington$920K
- Rasika WhitesellWilmington$40K
- James FanelliWilmington$39K
- Tracey GlendenningWilmington$13K
- Chris GlendenningWilmington$11K
- Hilary CoxWilmington$9K
- Chad TisdaleWilmington$9K
- Osama SaidRaleigh$597K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.